World EU approves treatment for prostate cancer Zurich – The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis,... Read more 13 Dec, 2022
World First-ever licencing deal struck for cancer drug Geneva – Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed... Read more 20 Oct, 2022